当前位置:首页 > 文献互助 > 互助详情

Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial复制

用户EO9nReo4Hj6s 1小时前 6 10 已关闭

DOI: 10.1016/j.jtho.2025.12.080复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086425030217复制

其他信息:

出版社: Elsevier BV
作者: David Planchard; Hye Ryun Kim; Thatthan Suksombooncharoen; Rubi Li; Diego Cortinovis; Ji-Youn Han; Jens Samol; Yotsawaj Runglodvatana; Kang-Yun Lee; Gee-Chen Chang; Chun-Hui Lee; Dariusz Kowalski; Stephanie P.L. Saw; Yiqing Huang; Gerrina Ruiter; Myung-Ju Ahn; Tsung-Ying Yang; Cheng-Ta Yang; Aumkhae Sookprasert; Erica C. Nakajima; Jose Alfon; Robert McEwen; Yi-Ting Chang; James CH. Yang

互助时间线

2026-04-30 18:02:43 [关闭求助]

楼主用户EO9nReo4Hj6s关闭了求助

2026-04-30 18:01:10 [发起求助]